Eli Lilly (LLY) stock gained 1.4% on Friday. The Indianapolis laboratory sought an emergency use authorization from the U.S. Food & Drug Administration for its Baricitinib in combination with Remdesivir in the treatment of Covid-19 in adults and children over 2 years of age.
Gilead Sciences (GILD) losing -0.8 percent on Friday has suffered from a poor perception of its anti-coronavirus drug from the World Health Organization. W.H.O. advises that patients hospitalized for Covid-19 should not be prescribed Remdesivir medication by physicians. “There is currently no evidence that Remdesivir improves survival or the need for ventilation,” according to the W.H.O. Instead, the organization suggests that cheaper and usable steroids (Cortisone) be used to treat serious cases.
Intuit Inc (INTU) (-3.80 percent), the tech group having products like Turbotax and QuickBooks, beat the profit and revenue consensus in its fiscal first quarter. As a result, quarterly earnings more than tripled, while sales rose 14% to $1.3 billion. The GAAP, per share earnings have climbed by 245% to 75 cents per share. On an adjustment basis, EPS jumped by 129 percent to 94 cents per share.
The U.S. distributor of apparel and sports products, Foot Locker (FL) dropped -4.96 percent after reporting a surprise increase in like-for-like revenue in Q3, for a net income of $265 million or $2.52 per share. Net income was $125 million a year earlier and $1.16 per share respectively. Like-for-like growth was 7.7 percent in the third quarter. Non-GAAP sales were up 7% to $128 million or $1.21 per share, nearly twice the consensus. Revenues climbed by 9% to $2.11 billion. The retailer refrains from issuing next quarter forecast.
According to Reuters sources, Apollo Global (APO) (-3.40 percent), KKR & Co (KKR) (-0.73 percent), Bain Capital (BCSF) (-1.03 percent) and Carlyle Group (CG) (up 0.50 percent) are among the potential buyers of Japan’s Hitachi Metals, with the probable deal priced at or above $6.4 billion.